Inhibition of carnitine synthesis modulates protein contents of the cardiac sarcoplasmic reticulum Ca2+-ATPase and hexokinase type I in rat hearts ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2000-10

AUTHORS

Katsunori Yonekura, Yoko Eto, Ikuo Yokoyama, Akihiro Matsumoto, Seiryo Sugiura, Shin-ichi Momomura, Tsukasa Kirimoto, Yukio Hayashi, Masao Omata, Teruhiko Aoyagi

ABSTRACT

It was previously reported than inhibition of carnitine synthesis by 3-(2,2,2-trimethyl-hydrazinium) propionate (MET-88) restores left ventricular (LV) systolic and diastolic function in rats with myocardial infarction (MI). Preservation of the calcium uptake function of sarcoplasmic reticulum Ca2+-ATPase (SERCA2) is one of the possible mechanisms by which MET-88 alleviates hemodynamic dysfunction. To test this hypothesis, the effects of MET-88 on protein content of SERCA2 were evaluated using the same rat model of heart failure. Myocardial protein content of hexokinase, which is one of the key enzymes of glucose utilization, was also measured. Either MET-88 (MET-88 group) or a placebo (MI group) was administered for 20 days to rats with MI induced by coronary artery ligation. The control group underwent sham surgery (no ligation) and received placebo. In LV myocardial homogenates, the myocardial SERCA2 protein content was 32% lower (p<0.05) in the MI group than in the control group. However, in the MET-88 group myocardial SERCA2 content was the same as in the control group. Hexokinase I protein content was 29% lower (p<0.05) in the MI group compared with the control. In contrast, hexokinase II protein content did not differ significantly among the three groups. Consequently, inhibition of carnitine synthesis ameliorates depression of SERCA2 and hexokinase I protein content which may reduce tissue damage caused by MI. More... »

PAGES

343-348

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s003950070032

DOI

http://dx.doi.org/10.1007/s003950070032

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1044619516

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11099160


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calcium-Transporting ATPases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiovascular Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carnitine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hexokinase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Isoenzymes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Methylhydrazines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocardial Infarction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocardium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Sprague-Dawley", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sarcoplasmic Reticulum Calcium-Transporting ATPases", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yonekura", 
        "givenName": "Katsunori", 
        "id": "sg:person.0746234355.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746234355.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eto", 
        "givenName": "Yoko", 
        "id": "sg:person.01047361177.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047361177.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yokoyama", 
        "givenName": "Ikuo", 
        "id": "sg:person.01355412055.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355412055.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsumoto", 
        "givenName": "Akihiro", 
        "id": "sg:person.01235416167.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235416167.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sugiura", 
        "givenName": "Seiryo", 
        "id": "sg:person.01277502614.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277502614.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Momomura", 
        "givenName": "Shin-ichi", 
        "id": "sg:person.01242732453.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242732453.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Taiho Pharmaceutical Co., Ltd., Tokushima, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.419828.e", 
          "name": [
            "Taiho Pharmaceutical Co., Ltd., Tokushima, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kirimoto", 
        "givenName": "Tsukasa", 
        "id": "sg:person.01301742751.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301742751.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Taiho Pharmaceutical Co., Ltd., Tokushima, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.419828.e", 
          "name": [
            "Taiho Pharmaceutical Co., Ltd., Tokushima, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hayashi", 
        "givenName": "Yukio", 
        "id": "sg:person.01251615631.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251615631.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Omata", 
        "givenName": "Masao", 
        "id": "sg:person.0775700471.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775700471.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aoyagi", 
        "givenName": "Teruhiko", 
        "id": "sg:person.010646460075.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010646460075.48"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2000-10", 
    "datePublishedReg": "2000-10-01", 
    "description": "Abstract It was previously reported than inhibition of carnitine synthesis by 3-(2,2,2-trimethyl-hydrazinium) propionate (MET-88) restores left ventricular (LV) systolic and diastolic function in rats with myocardial infarction (MI). Preservation of the calcium uptake function of sarcoplasmic reticulum Ca2+-ATPase (SERCA2) is one of the possible mechanisms by which MET-88 alleviates hemodynamic dysfunction. To test this hypothesis, the effects of MET-88 on protein content of SERCA2 were evaluated using the same rat model of heart failure. Myocardial protein content of hexokinase, which is one of the key enzymes of glucose utilization, was also measured. Either MET-88 (MET-88 group) or a placebo (MI group) was administered for 20 days to rats with MI induced by coronary artery ligation. The control group underwent sham surgery (no ligation) and received placebo. In LV myocardial homogenates, the myocardial SERCA2 protein content was 32% lower (p<0.05) in the MI group than in the control group. However, in the MET-88 group myocardial SERCA2 content was the same as in the control group. Hexokinase I protein content was 29% lower (p<0.05) in the MI group compared with the control. In contrast, hexokinase II protein content did not differ significantly among the three groups. Consequently, inhibition of carnitine synthesis ameliorates depression of SERCA2 and hexokinase I protein content which may reduce tissue damage caused by MI.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s003950070032", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1016443", 
        "issn": [
          "0300-8428", 
          "1435-1803"
        ], 
        "name": "Basic Research in Cardiology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "95"
      }
    ], 
    "keywords": [
      "myocardial infarction", 
      "sarcoplasmic reticulum Ca2", 
      "MI group", 
      "carnitine synthesis", 
      "control group underwent sham surgery", 
      "control group", 
      "reticulum Ca2", 
      "myocardial protein content", 
      "underwent sham surgery", 
      "coronary artery ligation", 
      "same rat model", 
      "cardiac sarcoplasmic reticulum Ca2", 
      "hexokinase II protein content", 
      "ventricular systolic", 
      "diastolic function", 
      "heart failure", 
      "sham surgery", 
      "artery ligation", 
      "hemodynamic dysfunction", 
      "rat model", 
      "glucose utilization", 
      "myocardial homogenates", 
      "rat heart", 
      "tissue damage", 
      "placebo", 
      "hexokinase type I", 
      "infarction", 
      "rats", 
      "type I", 
      "inhibition", 
      "SERCA2", 
      "protein content", 
      "group", 
      "possible mechanism", 
      "uptake function", 
      "Ca2", 
      "systolic", 
      "surgery", 
      "dysfunction", 
      "key enzyme", 
      "depression", 
      "ligation", 
      "heart", 
      "homogenates", 
      "days", 
      "failure", 
      "propionate", 
      "damage", 
      "hexokinase", 
      "function", 
      "control", 
      "preservation", 
      "contrast", 
      "effect", 
      "hypothesis", 
      "mechanism", 
      "enzyme", 
      "utilization", 
      "synthesis", 
      "content", 
      "Abstract", 
      "model", 
      "calcium uptake function", 
      "group underwent sham surgery", 
      "LV myocardial homogenates", 
      "myocardial SERCA2 protein content", 
      "SERCA2 protein content", 
      "group myocardial SERCA2 content", 
      "myocardial SERCA2 content", 
      "SERCA2 content", 
      "II protein content", 
      "depression of SERCA2"
    ], 
    "name": "Inhibition of carnitine synthesis modulates protein contents of the cardiac sarcoplasmic reticulum Ca2+-ATPase and hexokinase type I in rat hearts with myocardial infarction", 
    "pagination": "343-348", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1044619516"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s003950070032"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11099160"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s003950070032", 
      "https://app.dimensions.ai/details/publication/pub.1044619516"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:10", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_327.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s003950070032"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s003950070032'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s003950070032'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s003950070032'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s003950070032'


 

This table displays all metadata directly associated to this object as RDF triples.

252 TRIPLES      21 PREDICATES      112 URIs      104 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s003950070032 schema:about N0308090604374966ba04a563d9ad6602
2 N10386faef65e4edabbb1795841ca0b01
3 N2ce1356083f647beab67feb200bbead4
4 N335b191f85ca40ff8870f1187428cbc9
5 N5847337dc46d41c18048be1b3bbf396c
6 N67ccb3c0a8d94fc1b487533317b207ce
7 N7a841ee3101e4b76859976f5c99823bf
8 N91f6f4cf11714b3485b4658a9ad9a85b
9 Nb02c8abfc8d04eeaafa4d7fca265c793
10 Nb0a5092f6f0a418aaac1f8ae187dc1d8
11 Ndfb8303dc0c14b6b8c1aec1e95ee4a21
12 Nec55e0bd9c644819b8ba84a0e99a3a2a
13 Nfa77a133e5534f708ffa917d9f21034c
14 anzsrc-for:11
15 anzsrc-for:1102
16 schema:author N92af07e1847e4b7880be63a2b30d1b56
17 schema:datePublished 2000-10
18 schema:datePublishedReg 2000-10-01
19 schema:description Abstract It was previously reported than inhibition of carnitine synthesis by 3-(2,2,2-trimethyl-hydrazinium) propionate (MET-88) restores left ventricular (LV) systolic and diastolic function in rats with myocardial infarction (MI). Preservation of the calcium uptake function of sarcoplasmic reticulum Ca2+-ATPase (SERCA2) is one of the possible mechanisms by which MET-88 alleviates hemodynamic dysfunction. To test this hypothesis, the effects of MET-88 on protein content of SERCA2 were evaluated using the same rat model of heart failure. Myocardial protein content of hexokinase, which is one of the key enzymes of glucose utilization, was also measured. Either MET-88 (MET-88 group) or a placebo (MI group) was administered for 20 days to rats with MI induced by coronary artery ligation. The control group underwent sham surgery (no ligation) and received placebo. In LV myocardial homogenates, the myocardial SERCA2 protein content was 32% lower (p<0.05) in the MI group than in the control group. However, in the MET-88 group myocardial SERCA2 content was the same as in the control group. Hexokinase I protein content was 29% lower (p<0.05) in the MI group compared with the control. In contrast, hexokinase II protein content did not differ significantly among the three groups. Consequently, inhibition of carnitine synthesis ameliorates depression of SERCA2 and hexokinase I protein content which may reduce tissue damage caused by MI.
20 schema:genre article
21 schema:inLanguage en
22 schema:isAccessibleForFree false
23 schema:isPartOf N638ab1d849a9428a9944e3ef8b709ec4
24 N6c20e2b6f3994fd1b4e18b705564dbbd
25 sg:journal.1016443
26 schema:keywords Abstract
27 Ca2
28 II protein content
29 LV myocardial homogenates
30 MI group
31 SERCA2
32 SERCA2 content
33 SERCA2 protein content
34 artery ligation
35 calcium uptake function
36 cardiac sarcoplasmic reticulum Ca2
37 carnitine synthesis
38 content
39 contrast
40 control
41 control group
42 control group underwent sham surgery
43 coronary artery ligation
44 damage
45 days
46 depression
47 depression of SERCA2
48 diastolic function
49 dysfunction
50 effect
51 enzyme
52 failure
53 function
54 glucose utilization
55 group
56 group myocardial SERCA2 content
57 group underwent sham surgery
58 heart
59 heart failure
60 hemodynamic dysfunction
61 hexokinase
62 hexokinase II protein content
63 hexokinase type I
64 homogenates
65 hypothesis
66 infarction
67 inhibition
68 key enzyme
69 ligation
70 mechanism
71 model
72 myocardial SERCA2 content
73 myocardial SERCA2 protein content
74 myocardial homogenates
75 myocardial infarction
76 myocardial protein content
77 placebo
78 possible mechanism
79 preservation
80 propionate
81 protein content
82 rat heart
83 rat model
84 rats
85 reticulum Ca2
86 same rat model
87 sarcoplasmic reticulum Ca2
88 sham surgery
89 surgery
90 synthesis
91 systolic
92 tissue damage
93 type I
94 underwent sham surgery
95 uptake function
96 utilization
97 ventricular systolic
98 schema:name Inhibition of carnitine synthesis modulates protein contents of the cardiac sarcoplasmic reticulum Ca2+-ATPase and hexokinase type I in rat hearts with myocardial infarction
99 schema:pagination 343-348
100 schema:productId N1e97c287f95e45388e14cf776ec51bd9
101 Nc1d2f0a110004e0d97cb108a41917271
102 Nfbb16b57d0ca4731bbc031d7ea9597a5
103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044619516
104 https://doi.org/10.1007/s003950070032
105 schema:sdDatePublished 2022-01-01T18:10
106 schema:sdLicense https://scigraph.springernature.com/explorer/license/
107 schema:sdPublisher N250a1d28939f42cf8697c893ee810f91
108 schema:url https://doi.org/10.1007/s003950070032
109 sgo:license sg:explorer/license/
110 sgo:sdDataset articles
111 rdf:type schema:ScholarlyArticle
112 N0308090604374966ba04a563d9ad6602 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Male
114 rdf:type schema:DefinedTerm
115 N10386faef65e4edabbb1795841ca0b01 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Sarcoplasmic Reticulum Calcium-Transporting ATPases
117 rdf:type schema:DefinedTerm
118 N162b6e5346ee45d9b94d9f6700f7669a rdf:first sg:person.01242732453.82
119 rdf:rest N59063fb5d4224ede961be26f08de6ee4
120 N1e97c287f95e45388e14cf776ec51bd9 schema:name doi
121 schema:value 10.1007/s003950070032
122 rdf:type schema:PropertyValue
123 N250a1d28939f42cf8697c893ee810f91 schema:name Springer Nature - SN SciGraph project
124 rdf:type schema:Organization
125 N2ce1356083f647beab67feb200bbead4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Myocardium
127 rdf:type schema:DefinedTerm
128 N335b191f85ca40ff8870f1187428cbc9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Rats, Sprague-Dawley
130 rdf:type schema:DefinedTerm
131 N5847337dc46d41c18048be1b3bbf396c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Animals
133 rdf:type schema:DefinedTerm
134 N59063fb5d4224ede961be26f08de6ee4 rdf:first sg:person.01301742751.82
135 rdf:rest Nb1e6b5d4300d4377bea6404eb61d0841
136 N638ab1d849a9428a9944e3ef8b709ec4 schema:volumeNumber 95
137 rdf:type schema:PublicationVolume
138 N67ccb3c0a8d94fc1b487533317b207ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Calcium-Transporting ATPases
140 rdf:type schema:DefinedTerm
141 N6c20e2b6f3994fd1b4e18b705564dbbd schema:issueNumber 5
142 rdf:type schema:PublicationIssue
143 N7a841ee3101e4b76859976f5c99823bf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Isoenzymes
145 rdf:type schema:DefinedTerm
146 N91f6f4cf11714b3485b4658a9ad9a85b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Carnitine
148 rdf:type schema:DefinedTerm
149 N92af07e1847e4b7880be63a2b30d1b56 rdf:first sg:person.0746234355.31
150 rdf:rest Nf2013285239b4c749417eb2abaf2700d
151 N9ad8854fabf441178885d563a811e551 rdf:first sg:person.010646460075.48
152 rdf:rest rdf:nil
153 Na079f8839c8a4b3c8bfa6eb89472627e rdf:first sg:person.01277502614.69
154 rdf:rest N162b6e5346ee45d9b94d9f6700f7669a
155 Nb02c8abfc8d04eeaafa4d7fca265c793 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Cardiovascular Agents
157 rdf:type schema:DefinedTerm
158 Nb0a5092f6f0a418aaac1f8ae187dc1d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Methylhydrazines
160 rdf:type schema:DefinedTerm
161 Nb1e6b5d4300d4377bea6404eb61d0841 rdf:first sg:person.01251615631.78
162 rdf:rest Ncbf6e97266fa4a9abc2366b8f90dd237
163 Nc1d2f0a110004e0d97cb108a41917271 schema:name dimensions_id
164 schema:value pub.1044619516
165 rdf:type schema:PropertyValue
166 Ncb8480f0b1cd474c9e3531c3d86b237e rdf:first sg:person.01355412055.69
167 rdf:rest Nd6f3299468194b63b52bc4b828f5ca84
168 Ncbf6e97266fa4a9abc2366b8f90dd237 rdf:first sg:person.0775700471.08
169 rdf:rest N9ad8854fabf441178885d563a811e551
170 Nd6f3299468194b63b52bc4b828f5ca84 rdf:first sg:person.01235416167.92
171 rdf:rest Na079f8839c8a4b3c8bfa6eb89472627e
172 Ndfb8303dc0c14b6b8c1aec1e95ee4a21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Hexokinase
174 rdf:type schema:DefinedTerm
175 Nec55e0bd9c644819b8ba84a0e99a3a2a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Myocardial Infarction
177 rdf:type schema:DefinedTerm
178 Nf2013285239b4c749417eb2abaf2700d rdf:first sg:person.01047361177.42
179 rdf:rest Ncb8480f0b1cd474c9e3531c3d86b237e
180 Nfa77a133e5534f708ffa917d9f21034c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Rats
182 rdf:type schema:DefinedTerm
183 Nfbb16b57d0ca4731bbc031d7ea9597a5 schema:name pubmed_id
184 schema:value 11099160
185 rdf:type schema:PropertyValue
186 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
187 schema:name Medical and Health Sciences
188 rdf:type schema:DefinedTerm
189 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
190 schema:name Cardiorespiratory Medicine and Haematology
191 rdf:type schema:DefinedTerm
192 sg:journal.1016443 schema:issn 0300-8428
193 1435-1803
194 schema:name Basic Research in Cardiology
195 schema:publisher Springer Nature
196 rdf:type schema:Periodical
197 sg:person.01047361177.42 schema:affiliation grid-institutes:grid.26999.3d
198 schema:familyName Eto
199 schema:givenName Yoko
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047361177.42
201 rdf:type schema:Person
202 sg:person.010646460075.48 schema:affiliation grid-institutes:grid.26999.3d
203 schema:familyName Aoyagi
204 schema:givenName Teruhiko
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010646460075.48
206 rdf:type schema:Person
207 sg:person.01235416167.92 schema:affiliation grid-institutes:grid.26999.3d
208 schema:familyName Matsumoto
209 schema:givenName Akihiro
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235416167.92
211 rdf:type schema:Person
212 sg:person.01242732453.82 schema:affiliation grid-institutes:grid.26999.3d
213 schema:familyName Momomura
214 schema:givenName Shin-ichi
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242732453.82
216 rdf:type schema:Person
217 sg:person.01251615631.78 schema:affiliation grid-institutes:grid.419828.e
218 schema:familyName Hayashi
219 schema:givenName Yukio
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251615631.78
221 rdf:type schema:Person
222 sg:person.01277502614.69 schema:affiliation grid-institutes:grid.26999.3d
223 schema:familyName Sugiura
224 schema:givenName Seiryo
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277502614.69
226 rdf:type schema:Person
227 sg:person.01301742751.82 schema:affiliation grid-institutes:grid.419828.e
228 schema:familyName Kirimoto
229 schema:givenName Tsukasa
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301742751.82
231 rdf:type schema:Person
232 sg:person.01355412055.69 schema:affiliation grid-institutes:grid.26999.3d
233 schema:familyName Yokoyama
234 schema:givenName Ikuo
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355412055.69
236 rdf:type schema:Person
237 sg:person.0746234355.31 schema:affiliation grid-institutes:grid.26999.3d
238 schema:familyName Yonekura
239 schema:givenName Katsunori
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0746234355.31
241 rdf:type schema:Person
242 sg:person.0775700471.08 schema:affiliation grid-institutes:grid.26999.3d
243 schema:familyName Omata
244 schema:givenName Masao
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775700471.08
246 rdf:type schema:Person
247 grid-institutes:grid.26999.3d schema:alternateName Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP
248 schema:name Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8655, E-mail: aoyagi-2im@h.u-tokyo.ac.jp, JP
249 rdf:type schema:Organization
250 grid-institutes:grid.419828.e schema:alternateName Taiho Pharmaceutical Co., Ltd., Tokushima, Japan, JP
251 schema:name Taiho Pharmaceutical Co., Ltd., Tokushima, Japan, JP
252 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...